Immune thrombocytopenic purpura in adults Review uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Dexamethasone
  • Purpura, Thrombocytopenic, Idiopathic
  • Rho(D) Immune Globulin
  • Splenectomy

abstract

  • Patients with platelet counts less than 30 x 10(9)/l or bleeding have to be treated but management decisions should also be based on lifestyle, age, and other medical conditions that may contribute to the risk of serious bleeding. An aggressive therapeutic approach is justified only in patients with platelet counts below 20 x 10(9)/l and those refractory to splenectomy. Newer therapies may be more targeted in their action.

publication date

  • September 2007

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MOH.0b013e3282b9748f

PubMed ID

  • 17934364

Additional Document Info

start page

  • 535

end page

  • 56

volume

  • 14

number

  • 5